Lawyer Profile
Michael H. Taylor
Vancouver, British Columbia
Overview
Michael Taylor has a thriving capital markets practice and is focused on representing Canadian public companies that are listed in both Canada and the United States. Michael is qualified in both British Columbia and Nevada and has extensive experience helping Canadian public companies navigate United States securities laws as they expand their public listings and financings into the United States. Michael has over 25 year of experience advising clients on all stages of the “going public” process, from corporate organization through to listing and public trading. In addition to assisting clients with stock exchange listings in both Canada and the United States, he is experienced in the completion of complex cross-border mergers, acquisitions and joint venture transactions. He also counsels clients on the completion of cross-border public offerings qualified by Canadian prospectus and US Securities and Exchange Commission registration statements. He assists issuers with ongoing continuous disclosure obligations and corporate governance requirements in both Canada and the United States.
Mining companies are increasingly looking to move out of Canada to avoid application of the Government of Canada's restrictions on Chinese investment.
On June 9, 2023, the U.S. Securities and Exchange Commission approved the clawback listing standards of the New York Stock Exchange.
Jun 11, 2018, CSA published Staff Notice 46-308 – Securities Law Implications for Offerings of Tokens providing regulatory guidance on token and coin offerings.
On October 28, 2025, Midnight Sun Mining Corp. completed its previously announced upsized "bought deal" financing for aggregate gross proceeds of C$30,475,575, including the full exercise of the Underwriters' Option.
On October 14, 2025, Fury Gold Mines Limited closed its previously announced CAD$18 Million brokered financing.
On May 26, 2025, Fury Gold Mines Limited completed its non-brokered private placement with Agnico Eagle Mines Limited.
Bright Minds Bioscience Inc. (CSE: DRUG, NASDAQ: DRUG) has closed a USD $35 million non-brokered private placement on November 4, 2024, issuing 1,612,902 common shares at USD $21.70 per share.
Practice Areas
Bar Information
Called to the bar: 1991 (BC); 2000 (NV)